Details for New Drug Application (NDA): 086530
✉ Email this page to a colleague
NDA 086530 describes SECONAL SODIUM, which is a drug marketed by Valeant Pharms North and Lilly and is included in three NDAs. Additional details are available on the SECONAL SODIUM profile page.
The generic ingredient in SECONAL SODIUM is secobarbital sodium. There is one drug master file entry for this compound. Additional details are available on the secobarbital sodium profile page.
The generic ingredient in SECONAL SODIUM is secobarbital sodium. There is one drug master file entry for this compound. Additional details are available on the secobarbital sodium profile page.
Summary for 086530
| Tradename: | SECONAL SODIUM |
| Applicant: | Lilly |
| Ingredient: | secobarbital sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 086530
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUPPOSITORY;RECTAL | Strength | 30MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUPPOSITORY;RECTAL | Strength | 60MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUPPOSITORY;RECTAL | Strength | 120MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
